Autophagy Focus High throughput production of autophagy focused antibodies and a rapid launch of Autophagy Rapid Screening Kits indicate strong demand in autophagy research. This presents an opportunity to cross-sell premium antibodies, evaluation vials, and bundled screening solutions to labs targeting autophagy pathways.

In-House Reliability Most antibodies are produced in-house to ensure specificity, affinity, and reproducibility, reinforcing reliability for customers. Leverage this as a sales angle for customers needing consistent reagents for high-stakes experiments and longitudinal studies.

Proteome Coverage Aim for proteome-wide antibody coverage with the Crown line and extensive product catalog of over 10,000 products, enabling customers to consolidate sourcing and reduce vendor churn by offering broad access and comprehensive validation support.

Custom Services Strong capabilities in custom antibody development, peptide synthesis (including long peptides), and protein expression offer a pathway to bespoke project needs. Target CROs and pharma groups with customized reagent development and rapid turnaround promises.

Growth Signals Revenue in the multi-million range with a lean team (11-50 employees) suggests potential for partnerships and channel strategies to scale services, such as expanded distribution, co-marketing with WuXi AppTec resources, and targeted outreach to smaller biotechnology labs seeking affordable, reliable reagents.